Protein shake after liver transplant: simple fix for muscle loss?
NCT ID NCT07168369
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether giving liver transplant patients a daily high-protein drink for 12 weeks helps them maintain muscle mass. Thirty patients on the transplant list took part. Researchers measured muscle mass with CT scans and tracked how well patients stuck with the drink. The main goal was to see if such a study is even possible, not yet to prove the drink works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
protein and energy-rich oral supplement (Ensure Protéine Max or Boost Diabetic)
What this could lead to
If successful, this could show that a simple nutritional drink helps liver transplant patients keep muscle strength and improve recovery.
What could go wrong
This is a very small feasibility study (30 people) with no phase, so results are preliminary. The supplement may not prevent muscle loss or improve outcomes in larger, longer trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de recherche du Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, H2X 0A9, Canada